Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2003

View Archived Issues

Improved results described for topical AA-2500 testosterone gel in male hypogonadism

Diversa acquires GlaxoSmithKline antifungal program

Potential efficacy of topiramate in long-term treatment of obesity

Pyridoquinoxaline DNA polymerase inhibitors for herpesvirus infections

New mGluR5 antagonists, their preparation and use reported by Merck

Novel VR1 antagonists and their use in pain and urinary incontinence

Recent patent covers novel factor Xa inhibitors

CV Technologies describes new agents with utility in depression and neuroprotection

New PPARalpha and/or PPARgamma agonists in Biovitrum pipeline

Erectile function and treatment satisfaction best following penile implant surgery

Inhibition of inducible nitric oxide synthase has therapeutic potential in asthma

Simultaneous use of repaglinide and gemfibrozil may increase risk of hypoglycemia

Tanabe Seiyaku to market valganciclovir in Japan

Ciprodex Otic approved for two ear infection indications

Skyepharma submits DepoMorphine NDA

Two new INDs cleared for Thymoglobulin

Roche acquires Cardion's IL-15 antagonist

Preclinical evaluation of A-350619: a potential novel treatment for sexual dysfunction

NO-releasing NCX-972 is more potent than metronidazole in killing E. histolytica

Selective MRP1-mediated multidrug resistant modulator characterized by Vertex

NO-releasing ciprofloxacin active against M. tuberculosis in vitro

BMS evaluates the potential of agonist antibodies targeting CD137 for antitumor therapy

WX-508, an orally available uPA inhibitor as a promising new cancer therapeutic

G-quartet oligodeoxynucleotide targeting Stat3 demonstrates antitumor activity

UMass team discovers small-molecule inhibitors of Tat-TAR with anti-HIV activity

Discodermolide analogue NC2-86 has promising biological profile

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...